Drug Trial Radar · NCT04649359
MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb
Last checked: Nov 20, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
187
Actual
Start
Feb 2, 2021
Primary completion
Jun 17, 2022
Study completion Aug 25, 2026
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Dec 2, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to evaluate whether single-agent Elranatamab (PF-06863135) can provide clinical benefit in participants with relapsed/refractory multiple myeloma. Elranatamab is a bispecific antibody: binding of Elranatamab to CD3-expressing T-cells and BCMA-expressing multiple myeloma cells causes targeted T-cell-mediated cytotoxicity.
Conditions
- Multiple Myeloma
Interventions
Elranatamab (PF-06863135)Drug
BCMA-CD3 bispecific antibody
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective Response Rate (ORR) by Blinded Independent Central Review (BICR) as Per International Myeloma Working Group (IMWG) CriteriaTime frame: From date of first dose until confirmed disease progression, death, start of new anticancer therapy, whichever occurred first (up to approximately 16 months)
Locations
78 sites in 10 countries. Site status is shown where the registry gives one.
Beverly Hills Cancer Center
Beverly Hills, California
Chao Family Comprehensive Cancer Center and Ambulatory Care
Irvine, California
The Regents of the University of California
Irvine, California
UCLA Hematology/Oncology Clinic
Los Angeles, California
UCLA Ronald Reagan Medical Center
Los Angeles, California
UC Irvine Health - Chao Family Comprehensive Cancer Center
Orange, California
Baptist Hospital of Miami
Miami, Florida
Miami Cancer Institute
Miami, Florida
Winship Cancer Institute @ Emory University Hospital Midtown
Atlanta, Georgia
Emory University Hospital
Atlanta, Georgia
Winship Cancer Institute, Emory University
Atlanta, Georgia
Blood and Marrow Transplant Group of Georgia
Atlanta, Georgia
Emory Saint Joseph's Hospital
Atlanta, Georgia
Northside Hospital
Atlanta, Georgia
Northwestern Medical Group
Chicago, Illinois
Northwestern Memorial Hospital
Chicago, Illinois
Loyola University Chicago performing research at Loyola University Medical Center
Maywood, Illinois
Indiana Blood and Marrow Transplantation
Indianapolis, Indiana
University of Iowa - Holden Comprehensive Cancer Center
Iowa City, Iowa
Norton Cancer Institute, St. Matthews Campus
Louisville, Kentucky
Norton Women's and Children's Hospital
Louisville, Kentucky
Ochsner Clinic Foundation
New Orleans, Louisiana
Massachusetts General Hospital
Boston, Massachusetts
Hackensack University Medical Center
Hackensack, New Jersey
John Theurer Cancer Center at Hackensack University Medical Center
Hackensack, New Jersey
Roswell Park Cancer Institute
Buffalo, New York
Memorial Sloan Kettering Cancer Center-Investigational Drug Service Pharmacy
Long Island City, New York
Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street).
New York, New York
Weill Cornell Medical College - New York Presbyterian Hospital
New York, New York
Weill Cornell Medical College - New York-Presbyterian Hospital
New York, New York
Memorial Sloan Kettering Cancer Center
New York, New York
Weill Cornell Medical College - New York Presbyterian Hospital
New York, New York
Fox Chase Cancer Center
Philadelphia, Pennsylvania
St. Francis Hospital
Greenville, South Carolina
Saint Francis Hospital Cancer Center
Greenville, South Carolina
St Francis Eastside
Greenville, South Carolina
Baylor University Medical Center
Dallas, Texas
Epworth Healthcare
East Melbourne, Victoria, Australia
St Vincent's Hospital (Melbourne)
Fitzroy, Victoria, Australia
The Alfred
Melbourne, Victoria, Australia
Showing 40 of 78 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.